Dual Vaccine Shows Promise for Treating Alzheimer’s in Early Study

A dual vaccine targeting both amyloid plaques and tangled fibers made up of tau — two abnormal protein aggregates that build up in the brain of those with Alzheimer’s — may have potential to treat and prevent the disease. Prothena, its developer, has found preclinical evidence that the vaccine drives the generation of a sufficient amount of antibodies that are able to bind to and neutralize both amyloid and tau proteins, with reasonable safety. These…

You must be logged in to read/download the full post.